Peri-Implantitis Market Size to Reach USD 2,087.3 Million by 2033 | Growing at a CAGR of 7.69%

Market Overview

The global peri-implantitis market was valued at USD 1,071.6 Million in 2024 and is projected to reach USD 2,087.3 Million by 2033, growing at a CAGR of 7.69% during 2025-2033. Market growth is driven by growing awareness, an aging population demanding dental implants, technological improvements, and increasing collaborations in the dental implant industry. This rising demand promotes advancements in aesthetic dental implant treatments and infrastructure globally.

Study Assumption Years
• Base Year: 2024
• Historical Years: 2019-2024
• Forecast Period: 2025-2033

Peri-Implantitis Market Key Takeaways

• Current Market Size: USD 1,071.6 Million in 2024
• CAGR: 7.69% (2025-2033)
• Forecast Period: 2025-2033
• Key drivers include consumers who demand aesthetic dental implants with manufacturers, implant providers, and research institutions that collaborate.
• Healthcare infrastructures improve, making dental implant procedures more available.
• Surgical methods dominate market share over non-surgical methods, because they provide more precise and complete debridement.
• Hospitals therefore remain the largest end-users due to their multidisciplinary approach and advanced diagnostics.
• Europe commands the largest share of the market due to its established healthcare infrastructure and research institutes.

Request for a Free Sample of this Report: https://www.imarcgroup.com/peri-implantitis-market/requestsample

Market Growth Factors

The global peri-implantitis market is expected to grow due to factors such as changing consumer inclination towards aesthetic dental implants. The demand for the dental implants is increasing among the patients, as implants provide a natural look and increase the quality of life. Another factor driving market growth is the increasing senior population. Most individuals in this age category are candidates for the procedure due to the need for oral function and aesthetics. Increasing rates of dental implants also cause increased need for peri-implantitis treatment.

Recent developments in implant design, including biocompatible materials such as titanium alloys, zirconia and antibacterial coatings, have reduced the rate of infection and improved the efficacy of treatment for peri-implantitis. Factors such as the rise in ease of use for patients and dental practitioners, and advancements in non-surgical and surgical treatment methods that allow for more precise entry into infected implant sites, promote healing and reduce recovery time, are also expected to benefit the market.

Additionally, the demand for dental implants in developing countries is due to improved healthcare infrastructure, and new developments in the industry are occurring as a result of collaborative programs undertaken between dental implant manufacturers, healthcare providers and research institutions. The collaboration is fueling exchange of ideas for the treatment of peri-implantitis. The market is also expected to grow due to the popularity of dental tourism for cost-effective dentistry and its ability to expand the global patient pool for improved treatments and preventative care.

Market Segmentation:

By Method Type:
• Surgical:
• Bone Regeneration: Techniques aimed at regenerating bone tissue around implants to restore stability.
• Open Flap Debridement: Surgical exposure and cleaning of implant surfaces to remove infection.
• Implantoplasty: Physical modification and smoothening of implant surfaces to reduce bacterial accumulation.
• Non-Surgical:
• Mechanical Debridement: Non-invasive cleaning procedures to remove plaque and debris from implants.
• Laser Debridement: Use of laser technology to disinfect and clean implant areas.
• Antibiotics: Medication to control infection and inflammation around implants.
• Others: Additional non-surgical approaches employed for peri-implantitis treatment.

Surgical interventions allow for more targeted treatment and the ability to fully decontaminate the tissue, while non-surgical techniques are less intrusive, less expensive, and stress patient education and motivation.

By End User:

• Hospitals: Equipped with diverse healthcare professionals and advanced diagnostic tools to provide multidisciplinary peri-implantitis management.
• Dental Clinics: Widespread and accessible facilities staffed by skilled dental professionals providing timely treatment and follow-up care.
• Others: Not specifically defined in the report.
Hospitals dominate as they provide thorough, team-based care supported by most advanced technology.

By Region:

• North America: Includes the United States and Canada.
• Europe: Comprises Germany, France, the United Kingdom, Italy, Spain, and others.
• Asia Pacific: Includes China, Japan, India, South Korea, Australia, Indonesia, and others.
• Latin America: Brazil, Mexico, and others.
• Middle East and Africa: Not further broken down.

Regional Insights

The largest share of the global market revenue in peri-implantitis is from the Europe region. This region is expected to grow as it has many hospitals with modern healthcare facilities and dental departments. Europe leads the world with innovations and complex diagnostics for effective management of peri-implantitis cases are present. Europe is home to world-class research centers with implantology and prevention measures expertise, and a well-trained dental workforce.

Key Players
• botiss biomaterials GmbH
• Geistlich Pharma AG
• Silveraid S.r.l.
• Straumann Holding AG

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as part of the customization.

Ask Our Expert & Browse Full Report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=11686&flag=E

Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302

About Us
IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

This release was published on openPR.